Dana M Roque

11PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Sep 06, 2023
Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis.

Barry J Liang, Sumiao Pang, Robert Perttila

|Aug 18, 2022
Pap smear outcomes in elderly women living with HIV and HIV-negative matched controls.

Kylie L Klein, Abby R Goron, Gregory H Taylor

|Feb 15, 2022
Microtentacle Formation in Ovarian Carcinoma.

Jocelyn C Reader, Cong Fan, Eleanor Claire-Higgins Ory

|Feb 12, 2022
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Dana M Roque, Eric R Siegel, Natalia Buza

|Dec 24, 2021
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.

Joan Tymon-Rosario, Naomi N Adjei, Dana M Roque

Pageof 2

Frequent Collaborators

4 joint publications

Alessandro D Santin

4 joint publications

Huang-Chiao Huang

3 joint publications

Jocelyn Reader

3 joint publications

Natalia Buza